Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | QURE |
---|---|---|
09:32 ET | 40161 | 4.8847 |
09:34 ET | 7694 | 4.845 |
09:36 ET | 20757 | 4.8817 |
09:38 ET | 11777 | 4.965 |
09:39 ET | 55698 | 5.01 |
09:41 ET | 13372 | 5.03 |
09:43 ET | 27539 | 5.02 |
09:45 ET | 7924 | 5 |
09:48 ET | 18275 | 4.98 |
09:50 ET | 15272 | 5.07 |
09:52 ET | 16935 | 5.18 |
09:54 ET | 39971 | 5.13 |
09:56 ET | 74049 | 5.0689 |
09:57 ET | 20398 | 5.11 |
09:59 ET | 22159 | 5.08 |
10:01 ET | 5002 | 5.0382 |
10:03 ET | 23052 | 5 |
10:06 ET | 17539 | 4.9999 |
10:08 ET | 5021 | 5.0001 |
10:10 ET | 4037 | 4.98 |
10:12 ET | 19390 | 4.98 |
10:14 ET | 4427 | 4.94 |
10:15 ET | 2355 | 4.88 |
10:17 ET | 4643 | 4.88 |
10:19 ET | 1066 | 4.89 |
10:21 ET | 2622 | 4.925 |
10:24 ET | 2786 | 4.92 |
10:26 ET | 1559 | 4.92 |
10:28 ET | 2820 | 4.9086 |
10:30 ET | 887 | 4.87 |
10:32 ET | 585 | 4.895 |
10:33 ET | 1650 | 4.94 |
10:35 ET | 1700 | 4.95 |
10:37 ET | 4683 | 4.946 |
10:39 ET | 750 | 4.948 |
10:42 ET | 3879 | 4.95 |
10:44 ET | 3449 | 4.93 |
10:46 ET | 200 | 4.91 |
10:48 ET | 3267 | 4.9157 |
10:50 ET | 1168 | 4.91 |
10:51 ET | 7807 | 4.93 |
10:53 ET | 8223 | 4.95 |
10:55 ET | 6932 | 4.9283 |
10:57 ET | 4470 | 4.93 |
11:00 ET | 200 | 4.9322 |
11:02 ET | 9515 | 4.955 |
11:04 ET | 4255 | 4.9588 |
11:06 ET | 14446 | 4.99 |
11:08 ET | 13280 | 5.04 |
11:09 ET | 21316 | 5.09 |
11:11 ET | 5145 | 5.11 |
11:13 ET | 9252 | 5.09 |
11:15 ET | 7315 | 5.075 |
11:18 ET | 1241 | 5.055 |
11:20 ET | 500 | 5.06 |
11:22 ET | 1411 | 5.0131 |
11:24 ET | 1195 | 5 |
11:26 ET | 3588 | 5.065 |
11:27 ET | 932 | 5.07 |
11:29 ET | 4833 | 5.07 |
11:31 ET | 9586 | 5.05 |
11:33 ET | 7580 | 5.055 |
11:36 ET | 300 | 5.06 |
11:38 ET | 300 | 5.06 |
11:40 ET | 1090 | 5.065 |
11:42 ET | 4398 | 5.03 |
11:45 ET | 2837 | 5.02 |
11:47 ET | 3018 | 5.03 |
11:49 ET | 7370 | 5 |
11:51 ET | 4200 | 4.9804 |
11:54 ET | 1016 | 4.958 |
11:56 ET | 275 | 4.96 |
11:58 ET | 2447 | 4.97 |
12:00 ET | 705 | 4.97 |
12:02 ET | 1717 | 4.99 |
12:03 ET | 200 | 4.995 |
12:05 ET | 536 | 4.99 |
12:07 ET | 400 | 5.015 |
12:09 ET | 4557 | 5.03 |
12:12 ET | 5741 | 5.055 |
12:14 ET | 1100 | 5.06 |
12:16 ET | 5600 | 5.04 |
12:18 ET | 1275 | 5.05 |
12:20 ET | 1250 | 5.07 |
12:21 ET | 350 | 5.06 |
12:23 ET | 5278 | 5.1 |
12:25 ET | 7343 | 5.07 |
12:27 ET | 1166 | 5.07 |
12:30 ET | 400 | 5.0706 |
12:32 ET | 2525 | 5.09 |
12:34 ET | 5533 | 5.09 |
12:36 ET | 2392 | 5.11 |
12:38 ET | 400 | 5.106 |
12:39 ET | 6753 | 5.1088 |
12:41 ET | 2113 | 5.1016 |
12:43 ET | 659 | 5.1178 |
12:45 ET | 10786 | 5.15 |
12:48 ET | 475 | 5.1599 |
12:50 ET | 7997 | 5.15 |
12:52 ET | 2399 | 5.1426 |
12:54 ET | 15100 | 5.15 |
12:56 ET | 2850 | 5.15 |
12:57 ET | 4128 | 5.13 |
12:59 ET | 1019 | 5.14 |
01:01 ET | 784 | 5.1595 |
01:03 ET | 5780 | 5.16 |
01:06 ET | 13499 | 5.21 |
01:08 ET | 2494 | 5.18 |
01:10 ET | 300 | 5.17 |
01:12 ET | 844 | 5.175 |
01:14 ET | 3770 | 5.2 |
01:15 ET | 200 | 5.21 |
01:17 ET | 466 | 5.21 |
01:19 ET | 636 | 5.21 |
01:21 ET | 11135 | 5.22 |
01:24 ET | 1000 | 5.22 |
01:26 ET | 8039 | 5.2 |
01:28 ET | 575 | 5.1918 |
01:30 ET | 2400 | 5.19 |
01:32 ET | 15349 | 5.18 |
01:33 ET | 300 | 5.185 |
01:35 ET | 2722 | 5.17 |
01:37 ET | 3436 | 5.14 |
01:39 ET | 2202 | 5.12 |
01:42 ET | 332 | 5.13 |
01:44 ET | 1918 | 5.15 |
01:46 ET | 430 | 5.16 |
01:48 ET | 1500 | 5.14 |
01:50 ET | 200 | 5.15 |
01:51 ET | 2641 | 5.185 |
01:53 ET | 1200 | 5.19 |
01:55 ET | 1361 | 5.19 |
01:57 ET | 1100 | 5.19 |
02:00 ET | 3738 | 5.18 |
02:02 ET | 738 | 5.18 |
02:04 ET | 440 | 5.175 |
02:06 ET | 1244 | 5.165 |
02:08 ET | 3881 | 5.17 |
02:09 ET | 828 | 5.18 |
02:11 ET | 1624 | 5.2 |
02:13 ET | 2355 | 5.22 |
02:15 ET | 5281 | 5.208 |
02:18 ET | 2113 | 5.1791 |
02:20 ET | 5900 | 5.185 |
02:22 ET | 741 | 5.19 |
02:24 ET | 300 | 5.2 |
02:26 ET | 427 | 5.2 |
02:27 ET | 100 | 5.2 |
02:29 ET | 16958 | 5.24 |
02:31 ET | 3427 | 5.23 |
02:33 ET | 660 | 5.2299 |
02:36 ET | 2439 | 5.235 |
02:38 ET | 1100 | 5.245 |
02:40 ET | 7166 | 5.235 |
02:42 ET | 827 | 5.245 |
02:44 ET | 3494 | 5.27 |
02:45 ET | 15909 | 5.2899 |
02:47 ET | 30269 | 5.33 |
02:49 ET | 11073 | 5.36 |
02:51 ET | 54394 | 5.4024 |
02:54 ET | 11984 | 5.42 |
02:56 ET | 16674 | 5.395 |
02:58 ET | 36832 | 5.44 |
03:00 ET | 2565 | 5.419 |
03:02 ET | 19842 | 5.408 |
03:03 ET | 25273 | 5.465 |
03:05 ET | 38730 | 5.46 |
03:07 ET | 18492 | 5.512901 |
03:09 ET | 5771 | 5.505 |
03:12 ET | 21185 | 5.49 |
03:14 ET | 11882 | 5.49 |
03:16 ET | 27355 | 5.51 |
03:18 ET | 19558 | 5.5 |
03:20 ET | 3084 | 5.5095 |
03:21 ET | 8517 | 5.52 |
03:23 ET | 22487 | 5.5742 |
03:25 ET | 32827 | 5.57 |
03:27 ET | 7421 | 5.569 |
03:30 ET | 1463 | 5.57 |
03:32 ET | 9502 | 5.57 |
03:34 ET | 28747 | 5.554 |
03:36 ET | 12126 | 5.51 |
03:38 ET | 9340 | 5.548 |
03:39 ET | 10293 | 5.5688 |
03:41 ET | 4160 | 5.56 |
03:43 ET | 7892 | 5.565 |
03:45 ET | 29039 | 5.5631 |
03:48 ET | 11276 | 5.55 |
03:50 ET | 5124 | 5.5767 |
03:52 ET | 33077 | 5.61 |
03:54 ET | 10781 | 5.62 |
03:56 ET | 31444 | 5.605 |
03:57 ET | 29073 | 5.615 |
03:59 ET | 170873 | 5.65 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Uniqure NV | 222.1M | -1.0x | --- |
Molecular Partners AG | 173.6M | -2.4x | --- |
Mediwound Ltd | 178.9M | -7.7x | --- |
ProQR Therapeutics NV | 148.7M | -6.7x | --- |
Vaxart Inc | 186.8M | -1.7x | --- |
Fulcrum Therapeutics Inc | 228.7M | -10.9x | --- |
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $222.1M |
---|---|
Revenue (TTM) | $27.7M |
Shares Outstanding | 48.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.93 |
EPS | $-5.92 |
Book Value | $4.34 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -872.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.